TAGLN and breast carcinoma: In this study, we utilized microarray expression profiling of AZA-treated breast cancer (BC) and non-tumorigenic breast (NTB) cell lines, and identified TAGLN gene to be a frequently hypermethylated gene and a potential future biomarker in breast cancer.